Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXAMI trial of exenatide after acute myocardial infarction treated with primary PCI
NL-OMON40038Phase 2Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Nov 2009
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial in myocardial infarction (MI) comparing Exenatide + standard treatment + PCI with Placebo + standard treatment + PCI (2 arms). Primary endpoint: Infarct size relative to area at risk by MRI. Started Nov 2009; status: active, not recruiting.
02
Drugs
exenatide
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NL-OMON40038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40038.